Exchange: NASDAQ·Updated 07:30 PM EDT
ABEO logo

ABEO Abeona Therapeutics Inc

$5.42
$0.065
(1.19%)
Today
Closed $5.42
$0.053
(0.98%)
After Hours
Reported EarningsAug 13
Mkt Cap$309.65M
Vol1.6M

About ABEO

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.
40

Bearish Sentiment

How do you feel about ABEO?

Advertisement|Remove ads.